Burberry's new CEO Joshua Schulman faces an uphill task to turn around the British luxury brand whose sales have declined sharply while its share price has dropped 40% this year, stoking speculation ...
GSK plans $800m US manufacturing investment Seaport docks $225m for its improved neuropsychiatry drugs Novo joins Lilly in asking FDA for ban on GLP-1 compounding ...